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e-mail addresses: ahmedalhabash@gmail.com, ahabash@ud.edu.sa (A. Al Habash).Faisal Malik a, Ahmed Al Habash b,⇑AbstractCentral retinal vein occlusion (CRVO) is a rare complication of scleroderma. Here we report a case of a 30-year-old man who was
diagnosed to have scleroderma in the rheumatology and dermatology clinic. During treatment with systemic steroids and immu-
nosuppressive therapy the patient developed a sudden decrease of vision in the right eye and was diagnosed to have right CRVO
with macular edema on fundus examination. After three consecutive Intravitreal bevacizumab (IVB) injections for macular edema,
best-corrected visual acuity (BCVA) improved from 20/80 to 20/25. All ocular and systemic causes of CRVO other than scleroderma
were excluded in our patient by thorough clinical examination and investigations, suggesting that scleroderma was the most pos-
sible etiology in his condition.
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Scleroderma or systemic sclerosis (SSc) is a generalized
chronic connective tissue disorder of unknown etiology.1
One of the critical abnormalities in SSc is a diffuse fibroprolif-
erative vasculopathy, most commonly involving the microvas-
culature system,2 which includes perivasculitis and fibrinoid
degeneration of blood vessels.1 Scleroderma usually appears
in patients between 35 and 55 years, women being 2–3 times
more frequently affected than men.1
Scleroderma patients commonly report eye problems,
with dry eyes being a typical complaint. Conjunctiva and eye-
lid abnormalities are also often seen, including injection, tel-
angiectatic vessels and stiff or tight eyelids. Diffuse iris
atrophies and lens opacities are also experienced, although
the use of corticosteroids as part of treatment is likely tobe the cause of the latter of these.1 However, involvement
of the posterior segment is often subclinical and visual loss
as a direct result of the disease is rare.
Here we report a case of Central retinal vein occlusion
(CRVO) with decreased vision, which is a rare complication
of scleroderma. Patient was treated with Intravitreal bev-
acizumab (IVB) injections for macular edema and responded
well with vision improvement. To our knowledge, CRVO with
scleroderma was reported only twice in the literature.3,4 We
herein report a third case with that very rare complication.Case report
A 30-year-old man was diagnosed as scleroderma in the
rheumatology and dermatology clinic three years ago. Hee:
al.com
Arabia.
Figure 2. OCT of the right macula on presentation showing macular
edema with neurosensory detachment.
Acute central retinal vein occlusion in scleroderma 157presented with features of thickening, tightening and indura-
tion of the facial skin. There were associated sclerodactyly,
periungual telangiectasia, digital pitting, calcinosis in the
right fourth finger and positive Raynaud’s phenomena. His-
tory was negative for any medical problems other than
scleroderma.
All investigations at presentation which include thyroid
functions, complete blood count (CBC), prothrombin time
(PT), partial thromboplastin time (PTT), random blood sugar
(RBS), renal function tests (RFTs), liver function tests (LFTs),
rheumatoid factor, HLA-B51, HLA-27, anti-double-stranded
DNA, anti-scleroderma antibody, anti-JO-1, anti-ribonucleo-
protein, anti-Sjogren’s antibody SSA, Anti-Sjogren’s antibody
SSB, C3, C4 complement levels, centromere protein anti-
body, Smith antibody, anti liver/kidney microsomal antibody
were not conclusive apart from positive anti-nuclear antibody
(ANA) speckled ((1:320)), erythrocyte sedimentation rate
(ESR) 67 mm/h normal (0–20) mm/h and C-reactive protein
(CRP) 0.4 mg/dl normal (0–0.3) mg/dl.
A treatment in the form of oral prednisolone and myco-
phenolate mofetil (Cellcept) was started since that time.
As the patient was on routine follow up in the ophthalmol-
ogy clinic for dry eye, an incidental finding of tortuous retinal
vessels in both eyes on fundus examination was documented.
Two years after the patient was diagnosed to have sclero-
derma, he presented to our clinic with a sudden decrease of
vision in the right eye of one-day duration. On examination
his Blood pressure was 125/75 mmHg, and best-corrected
visual acuity (BCVAs) were 20/80 and 20/20 in the right and
left eyes, respectively. Both pupils found to be normal with
no relative afferent pupillary defect (RAPD). Anterior seg-
ment was within normal for both eyes. Intraocular pressure
was normal in both eyes. The fundus of the right eye showed
tortuous vessels with multiple retinal hemorrhages, cotton
wool spots and optic nerve swelling (Fig. 1). Fundus fluores-
cein angiography (FFA) showed capillary nonperfusion of less
than 10 disk diameters. Macular edema and neurosensory
detachment were also detected in the right eye by optical
coherence tomography (OCT) (Fig. 2). Fundus examination
of the left eye showed mild tortuous vessels (Fig. 3).Figure 1. Tortuous vessels with multiple retinal hemorrhages, cotton
wool spots and optic nerve swelling in the fundus of the right eye.
Figure 3. Mild tortuous retinal vessels of the left eye.Based on the previous findings, a diagnosis of non-ische-
mic CRVO in the right eye was made, in which the patient
received three consecutive IVB injections for the macular
edema on monthly basis.
After six-months of follow up, his right BCVA was
improved to 20/25 and the macular edema was resolved
(Fig. 4). Retinal hemorrhages, cotton wool spots and optic
nerve swelling were resolved leaving only a track of some
sclerosed blood vessels with no neovascularization in the ret-
ina, iris or the iridocorneal angle. Intraocular pressure was
Figure 4. OCT of the right macula with normal thickness 6 month after
treatment with three consecutive IVB injections.
158 F. Malik, A. Al Habashwithin normal range. All causes of CRVO were excluded such
as hypertension, diabetes, glaucoma, blood dyscrasias, clot-
ting disorders, sickle cell disease and retinal vascular
diseases.
Discussion
Scleroderma is a systemic connective tissue disease of
unknown etiology. It is characterized by fibrous and degener-
ative changes in the skin and viscera.1 The most characteristic
feature of scleroderma is the increased collagen content in
the skin and visceral organs. The second characteristic fea-
ture is vascular disease, including Raynaud’s phenomenon
and diffuse microvasculopathy.5
The American College of Rheumatology provides diag-
nostic criteria for SSc. Major criteria include anterior sclero-
derma (thickening of the skin) affecting the arms, face, and/
or neck; and minor criteria involve digital pitting scars or loss
of the volar pads of the finger tips, bibasal pulmonary fibrosis
and sclerodactyly (sclerosis affecting the fingers or toes). SSc
is diagnosed when a patient has one major or two minor
criteria.6
Our patient fulfilled these criteria as he was having tight-
ening and induration of the skin of his face, sclerodactyly,
periungual telangiectasia, digital pitting, calcinosis and posi-
tive Raynaud’s phenomena.
The ocular manifestations of SSc are characterized by
marked heterogeneity. Eyelid skin abnormalities and kerato-
conjunctivitis sicca (KCS) are the most common SSc-related
ocular findings. In the posterior segment of the eye, retinalmicrovascular abnormalities indistinguishable from those
related to systemic hypertension are the most common find-
ings, and they seem to be associated with a severe capillaro-
scopic pattern.7 In our case the patient was on follow up for
dry eye and discovered incidentally to have tortuous retinal
vessels. Tortuous vessels documented before the presenta-
tion of CRVO indicates an abnormal retinal microvasculature.
A study of the retinal vasculature of scleroderma patients
using fluorescein angiography demonstrated abnormalities
of perfusion, which affected the choriocapillaries and small
choroidal arterioles. Most of these patients were normoten-
sive. These observations suggest that end-organ disease
due to retinal vessel involvement with scleroderma vascular
change does occur, even though uncommonly.8
CRVO affects 0.8 in 1000 people, and presents with vari-
able degrees of visual loss.9 Funduscopic exam typically
shows numerous retinal hemorrhages, dilated and tortuous
retinal veins, cotton-wool spots and the presence of macular
and optic disk edema.10 CRVO in our case was a non-ische-
mic type and showed favorable prognosis after treatment
with three consecutive IVB injections. It ended with no severe
complications such as neovascular glaucoma.
Ushiyama et al. studied the retinal findings in 29 patients
with SSc and reported a higher incidence of retinal changes
associated with vascular damage in SSc patients than in con-
trols (p = 0.01).11
CRVO in scleroderma is a rare complication, which was
found in our case and was reported only twice in the litera-
ture by Saari et al. and Littlejohn et al. in 1981.3,4 In our case
the patient had no other diseases, which could be the cause
of the CRVO, in contrast to the cases reported by Saari et al.
and Littlejohn et al. in which the patients suffered from other
systemic problems such as secondary polycythemia, cardio-
vascular insufficiency and pulmonary fibrosis.3,4
Endothelial cell dysfunction, which affects microvascula-
ture system, could be the cause of CRVO in our case. Thor-
ough history and examination of the skin and joint are
essential in a patient with CRVO.
In conclusion, continuous follow up is essential for
patients with scleroderma presenting with abnormal retinal
vasculature.Conflict of interest
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